- Status:
- Red
- Decision Date:
- November 2023
Comments
RED:
NICE TA915 -
Pegunigalsidase alfa for treating Fabry disease. NHSE commissioned (Decision date - November 2023)Red Drug Classifications
- 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
- 2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care
search again